In the US, the regulator approved an AI-based device for diagnosing skin cancer
[ad_1]
The US regulator FDA has approved an artificial intelligence-based device to detect three common types of skin cancer.
The FDA issued the approval after a study that showed the device has a 96% sensitivity in detecting skin cancer, writes Reuters.
The DermaSensor device detects the three most common types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma.
“DermaSensor is now FDA cleared! After 10 years and $25 million of active research and development, we are grateful to the FDA for their cooperation in achieving this milestone in the treatment of skin cancer”– wrote manufacturer on Twitter.
Also read: AI can be a reliable tool for diagnosing skin cancer – study
| Photo: alexraths/Depositphotos |
Skin cancer is usually detected by dermatoscopy – a doctor examines the skin for signs of cancer using a special magnifying glass or visual inspection.
However, the privately held Miami-based company’s device uses light and an AI-based algorithm to help doctors detect cancer. In particular, in suspicious birthmarks.
This AI-powered device could help primary care doctors detect signs of cancer in patients aged 40+.
“The device should be used on lesions that have already been evaluated as suspicious, not as a screening tool. The device should not be used as the sole diagnostic criterion or to confirm the diagnosis of skin cancer”– the FDA noted at the same time.
The regulator also requires the manufacturer to conduct additional post-marketing clinical trials of the effectiveness of the DermaSensor device in patients.
We will remind you that earlier doctors gave 7 tips on how to protect yourself from skin cancer.
We also found out whether nail lamps can cause skin cancer.
Read also: A disease that can start with a birthmark. What is melanoma and how is it treated?
[ad_2]
Original Source Link
